Dataset on patients with Recurrent Borderline Ovarian Tumors and Table with Review of Literature on Fertility and Oncologic Outcomes of patients with Borderline Ovarian Tumors.
Borderline tumors of the ovary
Conservative treatment
Fertility sparing surgery
Invasive Recurrence
Low-grade ovarian cancer
Radical surgery
Recurrence
Review of Literature
Journal
Data in brief
ISSN: 2352-3409
Titre abrégé: Data Brief
Pays: Netherlands
ID NLM: 101654995
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
02
04
2020
accepted:
23
04
2020
entrez:
13
5
2020
pubmed:
13
5
2020
medline:
13
5
2020
Statut:
epublish
Résumé
The data presented here is related to the research article entitled "FERTILITY-SPARING SURGERY AND REPRODUCTIVE-OUTCOMES IN PATIENTS WITH BORDERLINE OVARIAN TUMORS" by Plett et al. in Journal of Gynecologic Oncology [1] and is analysed and discussed in detail. 18 Patients with Recurrent Borderline Ovarian Tumors (BOT) were identified and listed in Table 1. All patients underwent treatment for primary BOT either per radical surgery (RS) or fertility sparing surgery (FSS) by the same team in Horst Schmidt Klinik (HSK) in Wiesbaden and the Department of Gynecology and Gynecologic Oncology at Kliniken Essen-Mitte between January 2000 and December 2018 and were followed up closely. Details on patients` and surgical characteristics are given as well as management of character of recurrent disease. In Table 2 important publications from the last 20 years are listed in order to visualize better the oncologic outcomes (invasive and non-invasive relapses) and calculated risks of recurrence with the purpose to understand better the important findings of the related article cited above.
Identifiants
pubmed: 32395597
doi: 10.1016/j.dib.2020.105653
pii: S2352-3409(20)30547-3
pii: 105653
pmc: PMC7206201
doi:
Types de publication
Journal Article
Langues
eng
Pagination
105653Informations de copyright
© 2020 The Authors.
Références
Int J Gynecol Cancer. 2018 Nov;28(9):1683-1691
pubmed: 30365457
Int J Gynecol Cancer. 2016 Oct;26(8):1399-406
pubmed: 27465897
Ann Oncol. 2014 Jan;25(1):166-71
pubmed: 24287939
Int J Gynecol Cancer. 2014 Sep;24(7):1206-14
pubmed: 25078337
Gynecol Oncol. 2001 Apr;81(1):63-6
pubmed: 11277651
Gynecol Oncol. 2009 Apr;113(1):75-82
pubmed: 19171373
Eur J Cancer. 2013 May;49(8):1905-14
pubmed: 23490647
J Obstet Gynaecol. 2019 Feb;39(2):253-258
pubmed: 30372646
Gynecol Oncol. 2006 May;101(2):255-60
pubmed: 16307793
Eur J Cancer. 2019 Apr;111:61-68
pubmed: 30826658
Oncotarget. 2017 Dec 6;8(70):115718-115729
pubmed: 29383195